|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 31/4375 | (2006.01) |
| (11) | Number of the document | 3947375 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20715020.2 |
| Date of filing the European patent application | 2020-03-25 | |
| (97) | Date of publication of the European application | 2022-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-03 |
| (46) | Date of publication of the claims translation | 2024-06-10 |
| (86) | Number | PCT/EP2020/058425 |
| Date | 2020-03-25 |
| (87) | Number | WO 2020/193660 |
| Date | 2020-10-01 |
| (30) | Number | Date | Country code |
| 19165664 | 2019-03-27 | EP |
| (72) |
FUCHSS, Thomas , DE
BECKER, Axel , DE
KUBAS, Holger , DE
GRAEDLER, Ulrich , DE
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazolonilchinolino junginiai ir jų terapinis panaudojimas |
| IMIDAZOLONYLQUINOLINE COMPOUNDS AND THERAPEUTIC USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 7 | 162.00 EUR |
| 2027-03-25 |